IDXX · Earnings call · 2026Q2T · Full report

Operating Margin Drivers

IDEXX LABORATORIES INC /DE · 2026-08-04 · Importance 46 · Surprise 40 · No source text

Comparable operating margin increased 110 basis points in the second quarter, while reported operating margin reached 35%. Comparable operating profit increased 12%, benefiting from recurring revenue growth, favorable product costs, and gross-margin expansion. IDEXX expects full-year comparable operating-margin improvement of 70 to 90 basis points and reported operating margin of 32.3% to 32.5%. Management plans incremental commercial and R&D investments during the second half, limiting third-quarter comparable margin expansion to 20 to 50 basis points.

Key facts

• Updated full year reported operating margin outlook is 32.3% to 32.5%, reflecting an increased expectation of 70 to 90 basis points for full year comparable operating margin improvement.
• For Q3, planning for modest comparable operating margin expansion of 20 to 50 basis points, with reported operating margins expected to be 32.5% to 32.8%.
• On a comparable basis we expect a 20 to 50 basis point operating margin benefit in Q3.
• Comparable operating profit gains were 12% in the quarter.
• Reported operating margins achieved 35% in the quarter.
• Comparable operating margin gains were 110 basis points in Q2.
• EPS in the quarter included a $0.14 per share benefit related to share-based compensation activity, compared to a $0.10 benefit in the prior year period.
• Q2 EPS was $4.27 per share, an increase of 18% as reported and 15% on a comparable basis.

Impact estimates